Literature DB >> 18752493

Prostate development and pathogenesis.

Axel A Thomson, Gerald R Cunha, Paul C Marker.   

Abstract

Mesh：

Year:  2008        PMID： 18752493     DOI： 10.1111/j.1432-0436.2008.00303.x

Source DB:  PubMed          Journal:  Differentiation        ISSN： 0301-4681            Impact factor:   3.880


× No keyword cloud information.
  5 in total

Review 1.  Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer.

Authors:  Simeng Wen; Hong-Chiang Chang; Jing Tian; Zhiqun Shang; Yuanjie Niu; Chawnshang Chang
Journal:  Am J Pathol       Date:  2014-11-26       Impact factor: 4.307

2.  Aging up-regulates ARA55 in stromal cells, inducing androgen-mediated prostate cancer cell proliferation and migration.

Authors:  Qingsong Zou; Di Cui; Shengjie Liang; Shujie Xia; Yifeng Jing; Bangmin Han
Journal:  J Mol Histol       Date:  2016-05-13       Impact factor: 2.611

3.  Label retention and stem cell marker expression in the developing and adult prostate identifies basal and luminal epithelial stem cell subpopulations.

Authors:  Jens Adam Ceder; Tilly Wilhelmina Aalders; Jack Antonius Schalken
Journal:  Stem Cell Res Ther       Date:  2017-04-26       Impact factor: 6.832

4.  GV1001 interacts with androgen receptor to inhibit prostate cell proliferation in benign prostatic hyperplasia by regulating expression of molecules related to epithelial-mesenchymal transition.

Authors:  Yejin Kim; Dahae Lee; Hyejung Jo; Cheolhyeon Go; Jongwon Yang; Dongmin Kang; Jae Seung Kang
Journal:  Aging (Albany NY)       Date:  2021-02-04       Impact factor: 5.682

5.  METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m6A-YTHDF2-dependent manner.

Authors:  Jiaren Li; Hanyu Yao; Jin Huang; Chao Li; Yichuan Zhang; Ran Xu; Zhenting Wang; Zhi Long; Jin Tang; Long Wang
Journal:  Cell Death Dis       Date:  2022-08-19       Impact factor: 9.685
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.